Research and Development

A large scale study of GlaxoSmithKline's type II diabetes candidate Syncria (albiglutide) has begun.Albiglutide is an investigational biological drug, and …

Genzyme has said it expects to get approval to make a Pompe disease treatment at a new US manufacturing unit …

Lilly has signed a new deal with Danish biotech company NeuroSearch and increased its presence further in the biologics sector.The …

Pharma must re-invent itself and inject new ideas into its business model by hiring talented people from outside the sector, …

GlaxoSmithKline and Idenix are to co-develop IDX899 for the treatment of HIV infection. Despite having eight marketed HIV products, GSK …

Bayer Schering Pharma has begun phase III trials of riociguat for treatment of two life-threatening conditions. Two trials will investigate …

Schering-Plough is to invest around $30 million in its early drug discovery work in Scotland. The company is investing a …

Pharma has always been a highly profitable industry, and has historically been among the best performing industrial sectors in terms …

David Gillen says he is a born optimist. But Pfizer UK’s medical director says this positive outlook doesn’t blind him …

A new study has found more evidence that hormone replacement therapy (HRT) may reduce a woman's risk of bowel cancer. …

Before the merger, Pfizer faced a significant contraction in sales. Datamonitor's analysis suggests that the company's sales were declining at …

How did you find your way into your current role?From the age of 11 I wanted to be a farmer. …

Cladribine, a new oral treatment for multiple sclerosis is on track for a mid-2009 filing after the release of encouraging …

The route map for companies wishing to sell medicines made in genetically-engineered animals has been drawn up by the FDA. …